Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
Edwards Lifesciences Corp., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
Based on: 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
The capital structure of the organization has undergone a significant transformation between March 2017 and December 2021, characterized by a systematic shift from liability-based financing to a stronger equity-based foundation. Total liabilities as a percentage of total liabilities and stockholders’ equity decreased from a peak of 48.10% in December 2017 to 31.36% by December 2021, indicating a consistent deleveraging trend over the analyzed period.
- Debt and Liability Trends
- A marked reduction in long-term debt is evident, falling from 17.74% in March 2017 to 7.01% in December 2021. This downward trajectory is mirrored in contingent consideration liabilities, which declined from 4.09% to 0.73% over the same timeframe. Current liabilities exhibited higher volatility early in the period, specifically peaking in December 2017 at 24.63% due to a temporary increase in short-term debt, before stabilizing between 11% and 13% from 2019 through 2021.
- Equity Composition and Growth
- Stockholders’ equity increased steadily from 57.37% in March 2017 to 68.64% in December 2021. This growth was primarily driven by a substantial increase in retained earnings, which rose from 34.45% in December 2017 to 71.37% by December 2021. Simultaneously, the company engaged in significant share repurchases, as evidenced by treasury stock increasing from -0.01% in September 2017 to -28.43% by December 2021, suggesting a strategy of returning value to shareholders while maintaining a strong equity base.
- Other Financial Obligations
- The emergence of a litigation settlement accrual is noted starting in December 2020 at 3.22%, which subsequently moderated to 2.25% by December 2021. Uncertain tax positions remained relatively stable throughout the period, fluctuating within a narrow range between 2.35% and 3.11%. Operating lease liabilities remained a marginal component of the total balance sheet, consistently staying below 1.1% across both current and long-term portions.
Overall, the financial data reflects a strategic transition toward a more conservative financial position. By reducing long-term debt and leveraging strong retained earnings, the organization has significantly improved its solvency profile and reduced its reliance on external borrowing to fund its operations and assets.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?